Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6145)
All Articles published online
|
Publishing Process of This Article
|
Dec 21, 2013 (publication date) through Apr 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tan ZM, Sun BC. Effects of antiviral therapy on preventing liver tumorigenesis and hepatocellular carcinoma recurrence. World J Gastroenterol 2013; 19(47): 8895-8901 [PMID: 24379613 DOI: 10.3748/wjg.v19.i47.8895] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v19/i47/8895.htm |
| Number | Citing Articles |
| 1 |
Neil Mehta, Monika Sarkar, Jennifer L. Dodge, Nicholas Fidelman, John P. Roberts, Francis Y. Yao. Intention to treat outcome of T1 hepatocellular carcinoma with the “wait and not ablate” approach until meeting T2 criteria for liver transplant listing. Liver Transplantation 2016; 22(2): 178 doi: 10.1002/lt.24360
|
| 2 |
Jordyn Silverstein, Garrett Roll, Jennifer L. Dodge, Joshua D. Grab, Francis Y. Yao, Neil Mehta. Donation After Circulatory Death Is Associated With Similar Posttransplant Survival in All but the Highest‐Risk Hepatocellular Carcinoma Patients. Liver Transplantation 2020; 26(9): 1100 doi: 10.1002/lt.25819
|
| 3 |
Wei Li, Hong Wu, Jun Han. Surgical outcomes of hepatocellular carcinoma invading hepatocaval confluence. Hepatobiliary & Pancreatic Diseases International 2016; 15(6): 593 doi: 10.1016/S1499-3872(16)60152-2
|
| 4 |
Junichi Shindoh, Kristoffer W. Brudvik, Jean‐Nicolas Vauthey. Holland‐Frei Cancer Medicine. 2017; : 1 doi: 10.1002/9781119000822.hfcm092
|
| 5 |
Jan-Hendrik Bockmann, Matin Kohsar, John M. Murray, Vanessa Hamed, Maura Dandri, Stefan Lüth, Ansgar W. Lohse, Julian Schulze-zur-Wiesch. High Rates of Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Metabolic and Cardiovascular Comorbidities. Microorganisms 2021; 9(5): 968 doi: 10.3390/microorganisms9050968
|
| 6 |
Wai Yeow Lee, Maulana Bachtiar, Cheryl C. S. Choo, Caroline G. Lee. Comprehensive review of Hepatitis B Virus‐associated hepatocellular carcinoma research through text mining and big data analytics. Biological Reviews 2019; 94(2): 353 doi: 10.1111/brv.12457
|
| 7 |
Taro Takami, Takahiro Yamasaki, Issei Saeki, Toshihiko Matsumoto, Yutaka Suehiro, Isao Sakaida. Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function. World Journal of Gastroenterology 2016; 22(32): 7252-7263 doi: 10.3748/wjg.v22.i32.7252
|
| 8 |
Cristina Stasi, Caterina Silvestri, Fabio Voller. Hepatitis B vaccination and immunotherapies: an update. Clinical and Experimental Vaccine Research 2020; 9(1): 1 doi: 10.7774/cevr.2020.9.1.1
|
| 9 |
Yinli Yang, Bingqing Zheng, Qiuju Han, Cai Zhang, Zhigang Tian, Jian Zhang. Targeting blockage of STAT3 inhibits hepatitis B virus-related hepatocellular carcinoma. Cancer Biology & Therapy 2016; 17(4): 449 doi: 10.1080/15384047.2016.1156257
|
| 10 |
Antonio Facciorusso, Mohamed A. Abd El Aziz, Ivan Cincione, Ugo Vittorio Cea, Alessandro Germini, Stefano Granieri, Christian Cotsoglou, Rodolfo Sacco. Angiotensin Receptor 1 Blockers Prolong Time to Recurrence after Radiofrequency Ablation in Hepatocellular Carcinoma patients: A Retrospective Study. Biomedicines 2020; 8(10): 399 doi: 10.3390/biomedicines8100399
|
| 11 |
Xiao-xiao He, Liang-liang Shi, Meng-jun Qiu, Qiu-ting Li, Meng-meng Wang, Zhi-fan Xiong, Sheng-li Yang. Molecularly targeted anti-cancer drugs inhibit the invasion and metastasis of hepatocellular carcinoma by regulating the expression of MMP and TIMP gene families. Biochemical and Biophysical Research Communications 2018; 504(4): 878 doi: 10.1016/j.bbrc.2018.08.203
|
| 12 |
Guangcong Zhang, Xiangnan Yu, Peng Liu, Xiaoxi Huang, Xuemei Jiang. Efficacy of Nucleoside Analogs for Chronic Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Treatment: A Meta-Analysis. Digestive Diseases and Sciences 2018; 63(12): 3207 doi: 10.1007/s10620-018-5252-8
|
| 13 |
Antonio Facciorusso, Valentina Del Prete, Nicola Crucinio, Nicola Muscatiello, Brian I Carr, Alfredo Di Leo, Michele Barone. Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients. Journal of Gastroenterology and Hepatology 2015; 30(11): 1643 doi: 10.1111/jgh.12988
|
| 14 |
Hop S. Tran Cao, Junichi Shindoh, Jean‐Nicolas Vauthey. Holland‐Frei Cancer Medicine. 2022; : 1 doi: 10.1002/9781119000822.hfcm092.pub2
|
| 15 |
Cristina Stasi, Stefano Milani. Evolving strategies for liver fibrosis staging: Non-invasive assessment. World Journal of Gastroenterology 2017; 23(2): 191-196 doi: 10.3748/wjg.v23.i2.191
|
| 16 |
Cristina Stasi, Caterina Silvestri, Fabio Voller, Francesco Cipriani. The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine. Journal of Infection and Public Health 2016; 9(4): 389 doi: 10.1016/j.jiph.2015.05.004
|
| 17 |
Shuqin Zhang, Shan Gao, Man Zhao, Yunxia Liu, Yanan Bu, Qiulei Jiang, Qiang Zhao, Lihong Ye, Xiaodong Zhang. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein. Cancer Letters 2017; 392: 94 doi: 10.1016/j.canlet.2017.02.003
|
| 18 |
Cristina Stasi, Elena Salomoni, Umberto Arena, Giampaolo Corti, Paolo Montalto, Filippo Bartalesi, Fabio Marra, Giacomo Laffi, Stefano Milani, Anna Linda Zignego, Massimo Pinzani. Non-invasive assessment of liver fibrosis in patients with HBV-related chronic liver disease undergoing antiviral treatment: A preliminary study. European Journal of Pharmacology 2017; 806: 105 doi: 10.1016/j.ejphar.2017.03.063
|
| 19 |
Naoki Yamamoto, Takahiro Yamasaki, Taro Takami, Koichi Uchida, Koichi Fujisawa, Toshihiko Matsumoto, Issei Saeki, Shuji Terai, Isao Sakaida. Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib. Journal of Clinical Biochemistry and Nutrition 2016; 58(3): 202 doi: 10.3164/jcbn.15-127
|
| 20 |
CHAOHUI ZUO, MAN XIA, QUNFENG WU, HAIZHEN ZHU, JINGSHI LIU, CHEN LIU. Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review). Oncology Letters 2015; 9(2): 527 doi: 10.3892/ol.2014.2727
|
| 21 |
Chaohui Zuo, Man Xia, Jingshi Liu, Xiaoxin Qiu, Xiong Lei, Ruocai Xu, Hanchun Liu, Jianliang Li, Yongguo Li, Qinglong Li, Hua Xiao, Yuan Hong, Xiaohong Wang, Haizhen Zhu, Qunfeng Wu, Michael Burns, Chen Liu. Transcatheter Arterial Chemoembolization Combined with Interferon-α is Safe and Effective for Patients with Hepatocellular Carcinoma after Curative Resection. Asian Pacific Journal of Cancer Prevention 2015; 16(1): 245 doi: 10.7314/APJCP.2015.16.1.245
|
| 22 |
Xiang-Qian Gu, Wei-Ping Zheng, Da-Hong Teng, Ji-San Sun, Hong Zheng. Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients. World Journal of Gastroenterology 2016; 22(9): 2749-2759 doi: 10.3748/wjg.v22.i9.2749
|